Natalie Andrews

It is not happy, the pharma industry, about this. They're saying it's going to hurt consumers, that government price setting is bad for American patients, that it could limit choices. The pharma industry, as Kennedy noted in the Roosevelt Room at the White House today, they are a strong lobbying organization that has a lot of money behind it that does focus in research and development.

It is not happy, the pharma industry, about this. They're saying it's going to hurt consumers, that government price setting is bad for American patients, that it could limit choices. The pharma industry, as Kennedy noted in the Roosevelt Room at the White House today, they are a strong lobbying organization that has a lot of money behind it that does focus in research and development.

And one reason why they have a lot of lobbyists is to get that research and development money to get those government grants. They're also a powerful force in Washington.

And one reason why they have a lot of lobbyists is to get that research and development money to get those government grants. They're also a powerful force in Washington.

Thank you.

Thank you.